Research output per year
Research output per year
- 1 - 50 out of 165 results
Search results
-
2019
Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer
Evron, E., Ben-David, A. M., Goldberg, H., Fried, G., Kaufman, B., Catane, R., Pfeffer, M. R., Geffen, D. B., Chernobelsky, P., Karni, T., Abdah-Bortnyak, R., Rosengarten, O., Matceyevsky, D., Inbar, M., Kuten, A. & Corn, B. W., 1 Mar 2019, In: Annals of Oncology. 30, 3, p. 412-417 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2018
Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience
Purim, O., Beny, A., Inbar, M., Shulman, K., Brenner, B., Dudnik, E., Bokstein, F., Temper, M., Limon, D., Matceyevsky, D., Sarid, D., Segal, A., Semenisty, V., Brenner, R., Peretz, T., Idelevich, E., Pelles-Avraham, S., Meirovitz, A., Figer, A., Russell, K., & 4 others, 1 Apr 2018, In: Targeted Oncology. 13, 2, p. 217-226 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2017
Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer
Ben-Horin, I., Kahan, P., Ryvo, L., Inbar, M., Lev-Ari, S. & Geva, R., 1 Sep 2017, In: Integrative Cancer Therapies. 16, 3, p. 258-262 5 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Does residual microscopic disease after chemoradiotherapy for locally advanced rectal cancer translate into a good clinical outcome?
Geva, R., Davidovics, H., Soyfer, S., Pelles-Avraham, S., Klausner, J. M., Inbar, M. & Tulchinsky, H., 1 Mar 2017, In: Colorectal Disease. 19, 3, p. 237-242 6 p.Research output: Contribution to journal › Article › peer-review
-
Regional Nodal Irradiation after Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis from the ALTTO Trial
Gingras, I., Holmes, E., De Azambuja, E., Nguyen, D. H. A., Izquierdo, M., Zujewski, J. A., Inbar, M., Naume, B., Tomasello, G., Gralow, J. R., Wolff, A. C., Harris, L., Gnant, M., Moreno-Aspitia, A., Piccart, M. J. & Azim, H. A., 1 Aug 2017, In: Journal of the National Cancer Institute. 109, 8, djw331.Research output: Contribution to journal › Article › peer-review
Open Access -
2016
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial
Zielinski, C., Láng, I., Inbar, M., Kahán, Z., Greil, R., Beslija, S., Stemmer, S. M., Zvirbule, Z., Steger, G. G., Melichar, B., Pienkowski, T., Sirbu, D., Petruzelka, L., Eniu, A., Nisenbaum, B., Dank, M., Anghel, R., Messinger, D. & Brodowicz, T., 1 Sep 2016, In: The Lancet Oncology. 17, 9, p. 1230-1239 10 p.Research output: Contribution to journal › Article › peer-review
-
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer
Vrdoljak, E., Marschner, N., Zielinski, C., Gligorov, J., Cortes, J., Puglisi, F., Aapro, M., Fallowfield, L., Fontana, A., Inbar, M., Kahan, Z., Welt, A., Lévy, C., Brain, E., Pivot, X., Putzu, C., González Martín, A., de Ducla, S., Easton, V. & von Minckwitz, G., Nov 2016, In: Annals of Oncology. 27, 11, p. 2046-2052 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer
Zielinski, C., Lang, I., Beslija, S., Kahan, Z., Inbar, M. J., Stemmer, S. M., Anghel, R., Vrbanec, D., Messinger, D. & Brodowicz, T., 19 Jan 2016, In: British Journal of Cancer. 114, 2, p. 163-170 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2014
Cytoreduction surgery with hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer improves progression-free survival, especially in BRCA-positive patients-A case-control study
Safra, T., Grisaru, D., Inbar, M., Abu-Abeid, S., Dayan, D., Matceyevsky, D., Weizman, A. & Klausner, J. M., 1 Nov 2014, In: Journal of Surgical Oncology. 110, 6, p. 661-665 5 p.Research output: Contribution to journal › Article › peer-review
-
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses
Brodowicz, T., Lang, I., Kahan, Z., Greil, R., Beslija, S., Stemmer, S. M., Kaufman, B., Petruzelka, L., Eniu, A., Anghel, R., Koynov, K., Vrbanec, D., Pienkowski, T., Melichar, B., Spanik, S., Ahlers, S., Messinger, D., Inbar, M. J. & Zielinski, C., 25 Nov 2014, In: British Journal of Cancer. 111, 11, p. 2051-2057 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Should a loop ileostomy closure in rectal cancer patients be done during or after adjuvant chemotherapy?
Tulchinsky, H., Shacham-Shmueli, E., Klausner, J. M., Inbar, M. & Geva, R., Mar 2014, In: Journal of Surgical Oncology. 109, 3, p. 266-269 4 p.Research output: Contribution to journal › Article › peer-review
-
The combination of gemcitabine and carboplatin shows similar efficacy in the treatment of platinum-resistant and platinum-sensitive recurrent epithelial ovarian cancer patients
Safra, T., Asna, N., Veizman, A., Shpigel, S., Matcejevsky, D., Inbar, M. & Grisaru, D., Mar 2014, In: Anti-Cancer Drugs. 25, 3, p. 340-345 6 p.Research output: Contribution to journal › Article › peer-review
-
The impact of overall radiotherapy treatment time and delay in initiation of radiotherapy on local control and distant metastases in gastric cancer
Soyfer, V., Geva, R., Michelson, M., Inbar, M., Shacham-Shmueli, E. & Corn, B. W., 23 Mar 2014, In: Radiation Oncology. 9, 1, 81.Research output: Contribution to journal › Article › peer-review
Open Access -
Weekly carboplatin with paclitaxel compared to standard three-weekly treatment in advanced epithelial ovarian carcinoma - A retrospective study
Safra, T., Shamai, S., Greenberg, J., Veizman, A., Shpigel, S., Matcejevsky, D., Pelles, S., Inbar, M., Levy, T. & Grisaru, D., Jan 2014, In: Gynecologic Oncology. 132, 1, p. 18-22 5 p.Research output: Contribution to journal › Article › peer-review
-
2013
Determinants of adherence to screening by colonoscopy in individuals with a family history of colorectal cancer
Bronner, K., Mesters, I., Weiss-Meilik, A., Geva, R., Rozner, G., Strul, H., Inbar, M., Halpern, Z. & Kariv, R., Nov 2013, In: Patient Education and Counseling. 93, 2, p. 272-281 10 p.Research output: Contribution to journal › Article › peer-review
-
Do individuals with a family history of colorectal cancer adhere to medical recommendations for the prevention of colorectal cancer?
Bronner, K., Mesters, I., Weiss-Meilnik, A., Geva, R., Rozner, G., Strul, H., Inbar, M., Halpern, Z. & Kariv, R., Dec 2013, In: Familial Cancer. 12, 4, p. 629-637 9 p.Research output: Contribution to journal › Article › peer-review
-
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Davies, C., Pan, H., Godwin, J., Gray, R., Arriagada, R., Raina, V., Abraham, M., Medeiros Alencar, V. H., Badran, A., Bonfill, X., Bradbury, J., Clarke, M., Collins, R., Davis, S. R., Delmestri, A., Forbes, J. F., Haddad, P., Hou, M. F., Inbar, M., Khaled, H., & 18 others, Mar 2013, In: The Lancet. 381, 9869, p. 805-816 12 p.Research output: Contribution to journal › Article › peer-review
-
2012
Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer
Lang, I., Inbar, M. J., Kahán, Z., Greil, R., Beslija, S., Stemmer, S. M., Kaufman, B., Zvirbule, Z., Steger, G. G., Messinger, D., Brodowicz, T. & Zielinski, C., Nov 2012, In: European Journal of Cancer. 48, 17, p. 3140-3149 10 p.Research output: Contribution to journal › Article › peer-review
-
The protective effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole: A prospective, randomized, phase II trial
Safra, T., Bernstein-Molho, R., Greenberg, J., Pelles-Avraham, S., Stephansky, I., Sarid, D., Inbar, M. J., Stemmer, S. M. & Geffen, D. B., Feb 2012, In: Oncology. 81, 5-6, p. 298-305 8 p.Research output: Contribution to journal › Article › peer-review
-
2011
Improved treatment of the breast and supraclavicular fossa based on a simple geometrical principle
Yavetz, D., Corn, B. W., Matceyevsky, D., Ben-Josef, R., Soyfer, V., Bershtein, I., Inbar, M., Ron, I., Jiveliouk, I. & Schifter, D., 2011, In: Medical Dosimetry. 36, 4, p. 434-439 6 p.Research output: Contribution to journal › Article › peer-review
-
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), 27 Aug 2011, In: The Lancet. 378, 9793, p. 771-784 14 p.Research output: Contribution to journal › Article › peer-review
-
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), 27 Aug 2011, In: The Lancet. 378, 9793, p. 771-784 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2010
An animal model for chemotherapy-associated steatohepatitis and its prevention by the oral administration of fatty acid bile acid conjugate
Keizman, D., Maimon, N., Ish-Shalom, M., Buchbut, D., Inbar, M., Klein, B., Bernheim, J., Goldiner, I., Leikin-Frenkel, A. & Konikoff, F., 1 Jan 2010, In: Cancer. 116, 1, p. 251-255 5 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: A prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)
Tomova, A., Bartsch, R., Brodowicz, T., Tzekova, V., Timcheva, C., Wiltschke, C., Gerges, D. A., Pawlega, J., Spanik, S., Inbar, M. & Zielinski, C. C., Jan 2010, In: Breast Cancer Research and Treatment. 119, 1, p. 169-176 8 p.Research output: Contribution to journal › Article › peer-review
-
Do oncologists engage in bereavement practices? a survey of the Israeli society of clinical oncology and radiation therapy (ISCORT)
Corn, B. W., Shabtai, E., Merimsky, O., Inbar, M., Rosenbaum, E., Meirovitz, A. & Wexler, I. D., 2010, In: Oncologist. 15, 3, p. 317-326 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2009
A feasibility study of weekly docetaxel with capecitabine in ovarian cancer: A promising combination of two active drugs with a potential for synergism
Safra, T., Bernstein Molho, R., Menzcher, J., Inbar, M., Grisaru, D. & Levy, T., Jun 2009, In: Chemotherapy. 55, 4, p. 298-302 5 p.Research output: Contribution to journal › Article › peer-review
-
Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma
Safra, T., Menczer, J., Bernstein, R. M., Shpigel, S., Matcejevsky, D., Inbar, M. J., Golan, A., Grisaru, D. & Levy, T., Aug 2009, In: Gynecologic Oncology. 114, 2, p. 215-218 4 p.Research output: Contribution to journal › Article › peer-review
-
Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant
Hall, M. J., Liberman, E., Dulkart, O., Galazan, L., Sagiv, E., Shmueli, E., Kazanov, D., Hallak, A., Moshkowitz, M., Figer, A., Kraus, S., Inbar, M., Neugut, A. I. & Arber, N., 2009, In: Annals of Oncology. 20, 9, p. 1517-1521 5 p.Research output: Contribution to journal › Article › peer-review
Open Access -
The co-occurrence of breast cancer and soft tissue sarcoma in a single cohort series
Geva, R., Jiveliouk, I., Inbar, M., Meller, I., Friedman, E. & Merimsky, O., Feb 2009, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 32, 1, p. 34-37 4 p.Research output: Contribution to journal › Article › peer-review
-
2008
Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy
Jiveliouk, I., Corn, B., Inbar, M. & Merimsky, O., Dec 2008, In: Oncology. 76, 1, p. 30-35 6 p.Research output: Contribution to journal › Article › peer-review
-
Fulvestrant in heavily pretreated metastatic breast cancer: Is it still effective as a very advanced line of treatment?
Safra, T., Greenberg, J., Ron, I. G., Ben-Yosef, R., Inbar, M., Sarid, D. & Yaal-Hahoshen, N., May 2008, In: Israel Medical Association Journal. 10, 5, p. 339-343 5 p.Research output: Contribution to journal › Article › peer-review
-
The complexity of management of pregnancy-associated malignant soft tissue and bone tumors
Bernstein Molho, R., Kollender, Y., Issakov, J., Bickels, J., Flusser, G., Azem, F., Alon, A., Inbar, M. J., Meller, I. & Merimsky, O., Mar 2008, In: Gynecologic and Obstetric Investigation. 65, 2, p. 89-95 7 p.Research output: Contribution to journal › Article › peer-review
-
2007
Decreased prevalence of asymptomatic choroidal metastasis in disseminated breast and lung cancer: Argument against screening
Barak, A., Neudorfer, M., Heilweil, G., Merimsky, O., Lowenstein, A., Inbar, M. & Yaal-Hahoshen, N., Jan 2007, In: British Journal of Ophthalmology. 91, 1, p. 74-75 2 p.Research output: Contribution to journal › Article › peer-review
-
Efficacy and toxicity of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancer
Safra, T., Menczer, J., Bernstein, R., Shpigel, S., Inbar, M. J., Grisaru, D., Golan, A. & Levy, T., Apr 2007, In: Gynecologic Oncology. 105, 1, p. 205-210 6 p.Research output: Contribution to journal › Article › peer-review
-
Nuclear and cytoplasmic expression of ErbB-4 in prostate cancer
Ben-Yosef, R., Sarid, D., Vexler, A., Lidawi, G., Inbar, M., Marmor, S., Starr, A. & Yaal Hahoshen, N., 2007, In: International Journal of Biological Markers. 22, 3, p. 181-185 5 p.Research output: Contribution to journal › Article › peer-review
-
2006
A biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, temozolomide (Temodal), interferon-alfa and interleukin-2 for metastatic melanoma: A phase II study
Ron, I. G., Sarid, D., Ryvo, L., Even Sapir, E., Schneebaum, S., Metser, U., Asna, N., Inbar, M. J. & Safra, T., 2006, In: Melanoma Research. 16, 1, p. 65-69 5 p.Research output: Contribution to journal › Article › peer-review
-
Brachytherapy combined with external beam radiation in localized prostate cancer
Matzkin, H., Mabjeesh, N., Stenger, A., Agai, R., Chen, J. & Inbar, M., Jan 2006, In: Harefuah. 145, 1 SPEC. ISS., p. 8-12 5 p.Research output: Contribution to journal › Article › peer-review
-
ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy
Starr, A., Greif, J., Vexler, A., Ashkenazy-Voghera, M., Gladesh, V., Rubin, C., Kerber, G., Marmor, S., Lev-Ari, S., Inbar, M., Yarden, Y. & Ben-Yosef, R., 15 Jul 2006, In: International Journal of Cancer. 119, 2, p. 269-274 6 p.Research output: Contribution to journal › Article › peer-review
-
Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patients
Safra, T., Ron, I., Boaz, M., Brenner, J., Grisaru, D., Inbar, M., Hayat, H., Menczer, J., Golan, A. & Levy, T., 1 Jun 2006, In: Acta Oncologica. 45, 4, p. 463-468 6 p.Research output: Contribution to journal › Article › peer-review
-
One year maintenance of carboplatin in patients with epithelial ovarian cancer - A phase II study
Safra, T., Kovner, F., Barak, N., Inbar, M. J. & Ron, I. G., Jan 2006, In: Israel Medical Association Journal. 8, 1, p. 27-29 3 p.Research output: Contribution to journal › Article › peer-review
-
The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT
Even-Sapir, E., Lerman, H., Gutman, M., Lievshitz, G., Zuriel, L., Polliack, A., Inbar, M. & Metser, U., May 2006, In: European Journal of Nuclear Medicine and Molecular Imaging. 33, 5, p. 541-552 12 p.Research output: Contribution to journal › Article › peer-review
-
2005
Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: A Central European Cooperative Oncology Group International, Multicenter, Prospective, Randomized Phase III Trial
Zielinski, C., Beslija, S., Mrsic-Krmpotic, Z., Welnicka-Jaskiewicz, M., Wiltschke, C., Kahan, Z., Grgic, M., Tzekova, V., Inbar, M., Cervek, J., Chernozemsky, I., Szanto, J., Spanik, S., Wagnerova, M., Ghilezan, N., Pawlega, J., Vrbanec, D., Khamtsov, D., Soldatenkova, V. & Brodowicz, T., 2005, In: Journal of Clinical Oncology. 23, 7, p. 1401-1408 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicity
Asna, N., Lewy, H., Ashkenazi, I. E., Deutsch, V., Peretz, H., Inbar, M. & Ron, I. G., 4 Mar 2005, In: Life Sciences. 76, 16, p. 1825-1834 10 p.Research output: Contribution to journal › Article › peer-review
-
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., Cameron, D., Dowsett, M., Barrios, C. H., Steger, G., Huang, C. S., Andersson, M., Inbar, M., Lichinitser, M., Láng, I., Nitz, U., & 12 others, 20 Oct 2005, In: New England Journal of Medicine. 353, 16, p. 1659-1672 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2004
Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment
Shmueli, E., Wigler, N. & Inbar, M., Feb 2004, In: European Journal of Cancer. 40, 3, p. 379-382 4 p.Research output: Contribution to journal › Article › peer-review
-
Evaluation of CaDet, a computer-based clinical decision support system for early cancer detection: A comparison with the performance of clinicians
Heller, I., Isakov, A., Villa, Y., Natour, H., Inbar, M., Fuchs, J., Blinder-Vayner, S., Shapira, I. & Topilsky, M., 2004, In: Cancer Detection and Prevention. 28, 5, p. 352-356 5 p.Research output: Contribution to journal › Article › peer-review
-
Hyperthermia combined with radiation therapy in the treatment of local recurrent breast cancer
Ben-Yosef, R., Vigler, N., Inbar, M. & Vexler, A., Jul 2004, In: Israel Medical Association Journal. 6, 7, p. 392-395 4 p.Research output: Contribution to journal › Article › peer-review
-
Phase II study of weekly topotecan in patients with recurrent or persistent epithelial ovarian cancer
Levy, T., Inbar, M., Menczer, J., Grisaru, D., Glezerman, M. & Safra, T., Dec 2004, In: Gynecologic Oncology. 95, 3, p. 686-690 5 p.Research output: Contribution to journal › Article › peer-review
-
Radiotherapy for spinal cord compression in patients with soft-tissue sarcoma
Merimsky, O., Kollender, Y., Bokstein, F., Issakov, J., Flusser, G., Inbar, M. J., Meller, I. & Bickels, J., 1 Apr 2004, In: International Journal of Radiation Oncology Biology Physics. 58, 5, p. 1468-1473 6 p.Research output: Contribution to journal › Article › peer-review
-
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX™/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
O'Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D. G., Tomczak, P., Ackland, S. P., Orlandi, F., Mellars, L., Alland, L. & Tendler, C., Mar 2004, In: Annals of Oncology. 15, 3, p. 440-449 10 p.Research output: Contribution to journal › Article › peer-review
Open Access